Skip to main content
Equibles

ALC · Alcon Inc · Metrics

Track ALC — free

Use ALC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ALC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$74.12 +2.29 (+3.19%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$35.61B
Shares
480.40M
Volume · Nov 13 2.79M Avg daily vol (3M) 1.82M

ALC metrics

92 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$74.12
Market cap
$35.61B

Price action

23 metrics
Price change (1W)
-1.1%
Price change (30D)
+11.3%
Price change (3M)
-0.2%
Price change (6M)
+16.5%
Price change (YTD)
-6.0%
Price change (1Y)
-5.7%
Trailing year
Price change (5Y)
-8.7%
52-week high
$87.18
52-week low
$62.02
Change from 52-week high
-15.0%
Change from 52-week low
+19.5%
Annualized volatility
29.0%
Annualized volatility (3M)
28.3%
Implied volatility (30D)
24.6%
IV rank (1Y)
14.2
IV percentile (1Y)
20.6
Beta
0.4
RSI (14D)
59.7
Price vs SMA 50
+9.0%
Price vs SMA 200
+3.5%
Avg volume (3M)
1.82M
Relative volume
1.5
Average dollar volume
$126.08M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
480.40M

Valuation

12 metrics
P / E (TTM)
55.4
Trailing earnings · reciprocal yield 1.8%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.3×
reciprocal yield 30.5%
P / book
1.6
reciprocal yield 60.6%
FCF yield
4.9%
TTM · current market cap
Buyback yield
2.6%
P / FCF
20.5
reciprocal yield 4.9%
P / operating cash flow
15.4
reciprocal yield 6.5%
Earnings yield
1.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.5%
Trailing 12 months
Payout ratio
27.1%
Shareholder yield
3.1%
Dividend / share (TTM)
$0.36
Dividend growth YoY
+8.2%
Dividend growth streak
4
Last ex-dividend
2026-05-05

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-11

Profitability

9 metrics
Gross margin
56.8%
Operating margin
8.7%
Trailing 12 months
Net margin
5.9%
Gross profit (TTM)
$6.17B
Operating profit (TTM)
$948.00M
Net income (TTM)
$643.00M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
16.0%
Effective tax rate
13.2%

Per share

11 metrics
Revenue per diluted share (TTM)
$23.61
Gross profit per diluted share (TTM)
$18.10
Operating profit per diluted share (TTM)
$8.14
EBITDA per diluted share (TTM)
$9.03
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
$7.81
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$2.46
Stock compensation per diluted share (TTM)
$0.26
Book value per share
$45.20

Growth

11 metrics
Revenue growth YoY
+8.7%
Year over year
Net income growth YoY
-100.0%
Revenue (TTM)
$10.86B
Trailing 12 months
EPS growth YoY
-100.0%
Shares change YoY
+1.0%
Year over year · more shares
Revenue CAGR (3Y)
+6.1%
Revenue CAGR (5Y)
+8.8%
EPS CAGR (3Y)
+42.8%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+43.8%
FCF CAGR (5Y)
+38.1%

Quality

14 metrics
Return on equity
3.0%
Return on assets
2.1%
Debt / equity
—
Current ratio
2.1
EBITDA (TTM)
—
Free cash flow (TTM)
$1.74B
Quick ratio
1.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.35B
Total assets
$31.10B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$2.31B
Capital expenditures (TTM)
$570.00M
R&D (TTM)
$1.43B
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
13.2%
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
637
13F filer change QoQ
-25
Institutional ownership
53.2%
Conviction holders (share of 13F filers)
1.6%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+3.0%
Holder tenure
17.1
Price vs estimated holder cost
-13.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.2%

Short interest

3 metrics
Short interest
3.8%
Latest settlement · 12.6 days to cover
Days to cover
12.6d
Short-squeeze score
82 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1167379 CUSIP H01301128 13F (30d) 527 filings 453 filers Visit website Investor relations